Are the endocannabinoid-like compounds N -acyl aminoacids neuroprotective after traumatic brain injury?
Authors:
- 13 November 2015
- journal article
- review article
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 27 (3) , 209-216
Abstract
In recent years, a library of approx. 70 N -acyl aminoacids (NAAAs) was discovered in the rat brain. A particular member of this family of compounds is arachidonoyl serine (AraS), which has generated special interest as a potential therapy for traumatic brain injury (TBI). This is due to its structural similarity to the endocannabinoid (eCB) 2-arachidonoyl glycerol (2-AG), which was previously shown to be beneficial in the recovery in a closed head injury model of TBI. Indeed, AraS exerted eCB-mediated neuroprotection, which was evident in numerous aspects related to the secondary damage characterizing TBI. These findings promoted broadening of the research to additional compounds of the NAAA family that share a structural similarity to AraS, namely, palmitoyl serine (PalmS) and oleoyl serine. The latter did not exhibit any improvement in recovery, whereas the former displayed some neuroprotection, albeit inferior to 2-AG and AraS, via unknown mechanisms. Interestingly, when a combined treatment of 2-AG, AraS and PalmS was tested, the overall effect on the severity score was inferior to their individual effects, suggesting not only a lack of direct or indirect synergism, but also possibly some spatial hindrance. Taken together, the complexity of the damage caused by TBI and the many open questions concerning the role of the eCB system in health and disease, the findings so far may serve as a small trace to the understanding of the eCB system, as well as of the mechanisms underlying TBI.Keywords
This publication has 41 references indexed in Scilit:
- Effects of palmitoylation of Cys415in helix 8 of the CB1cannabinoid receptor on membrane localization and signallingBritish Journal of Pharmacology, 2011
- Endocannabinoids and traumatic brain injuryBritish Journal of Pharmacology, 2011
- N-Arachidonoyl-l-Serine is Neuroprotective after Traumatic Brain Injury by Reducing ApoptosisJournal of Cerebral Blood Flow & Metabolism, 2011
- Oleoyl serine, an endogenous N -acyl amide, modulates bone remodeling and massProceedings of the National Academy of Sciences, 2010
- N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptorBMC Neuroscience, 2010
- Identification of endogenous acyl amino acids based on a targeted lipidomics approachJournal of Lipid Research, 2010
- Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's diseaseGlia, 2008
- Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injuryNeuroscience, 2008
- Cannabinoid CB2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion ModelJournal of Cerebral Blood Flow & Metabolism, 2007
- Targeting the endocannabinoid system in treating brain disordersExpert Opinion on Investigational Drugs, 2006